ES2146649T3 - POLYOXIME COMPOUNDS AND THEIR PREPARATION. - Google Patents
POLYOXIME COMPOUNDS AND THEIR PREPARATION.Info
- Publication number
- ES2146649T3 ES2146649T3 ES94913192T ES94913192T ES2146649T3 ES 2146649 T3 ES2146649 T3 ES 2146649T3 ES 94913192 T ES94913192 T ES 94913192T ES 94913192 T ES94913192 T ES 94913192T ES 2146649 T3 ES2146649 T3 ES 2146649T3
- Authority
- ES
- Spain
- Prior art keywords
- baseplate
- polyoxime
- preparation
- organic molecules
- organic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
- C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
A homogeneous polyoxime composition is provided, in which the polyoxime molecules present comprise a first organic baseplate molecule, which is a polypeptide, wherein the baseplate molecule is linked to at least two second organic molecules, which may be the same or different from one another. In the compositions, the linkages between the baseplate and said organic molecules are oxime linkages formed by reaction of an orthogonal reactive group on each the organic molecules with a complementary orthogonal reactive group on the baseplate.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5759493A | 1993-05-05 | 1993-05-05 | |
US08/114,877 US6174530B1 (en) | 1993-05-05 | 1993-08-31 | Homogeneous polyoxime compositions and their preparation by parallel assembly |
US08/105,904 US6001364A (en) | 1993-05-05 | 1993-08-31 | Hetero-polyoxime compounds and their preparation by parallel assembly |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2146649T3 true ES2146649T3 (en) | 2000-08-16 |
Family
ID=27369284
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES94913192T Expired - Lifetime ES2146649T3 (en) | 1993-05-05 | 1994-05-05 | POLYOXIME COMPOUNDS AND THEIR PREPARATION. |
Country Status (11)
Country | Link |
---|---|
US (1) | US6663869B1 (en) |
EP (1) | EP0697891B1 (en) |
JP (1) | JP3734828B2 (en) |
AT (1) | ATE191148T1 (en) |
AU (1) | AU686153B2 (en) |
CA (1) | CA2162157A1 (en) |
DE (1) | DE69423753T2 (en) |
DK (1) | DK0697891T3 (en) |
ES (1) | ES2146649T3 (en) |
GR (1) | GR3033699T3 (en) |
PT (1) | PT697891E (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20060026011A (en) * | 2003-05-09 | 2006-03-22 | 노보 노르디스크 에이/에스 | Peptides for use in treating obesity |
AU2004235872A1 (en) * | 2003-05-09 | 2004-11-18 | Novo Nordisk A/S | Peptides for use in treating obesity |
CN101222942A (en) * | 2005-07-18 | 2008-07-16 | 诺沃-诺迪斯克有限公司 | Peptides for use in the treatment of obesity |
US8795680B2 (en) * | 2006-07-21 | 2014-08-05 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Methods for conjugation of oligosaccharides or polysaccharides to protein carriers through oxime linkages via 3-deoxy-D-manno-octulsonic acid |
WO2008087190A2 (en) * | 2007-01-18 | 2008-07-24 | Novo Nordisk A/S | Use of peptides in combination with surgical intervention for the treatment of obesity |
WO2008087187A1 (en) * | 2007-01-18 | 2008-07-24 | Novo Nordisk A/S | Peptides for use in the treatment of obesity |
EP2106405A2 (en) * | 2007-01-18 | 2009-10-07 | Novo Nordisk A/S | Peptides for use in the treatment of obesity |
NZ602170A (en) | 2008-02-08 | 2014-03-28 | Ambrx Inc | Modified leptin polypeptides and their uses |
JP2012509862A (en) * | 2008-11-25 | 2012-04-26 | ノヴォ・ノルディスク・アー/エス | Peptides for the treatment of obesity |
US8647621B2 (en) | 2009-07-27 | 2014-02-11 | Fina Biosolutions, Llc | Method of producing protein-carbohydrate vaccines reduced in free carbohydrate |
JP6564539B1 (en) * | 2018-09-14 | 2019-08-21 | 長瀬産業株式会社 | Peptide purification method using sulfonic acid compound |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4444744A (en) | 1980-03-03 | 1984-04-24 | Goldenberg Milton David | Tumor localization and therapy with labeled antibodies to cell surface antigens |
US4622420A (en) | 1980-03-18 | 1986-11-11 | The Regents Of The University Of California | Chelating agents and method |
US4865835A (en) | 1982-06-02 | 1989-09-12 | Begent Richard H J | Diagnosis and treatment of tumors |
US4507466A (en) | 1983-01-07 | 1985-03-26 | The Dow Chemical Corporation | Dense star polymers having core, core branches, terminal groups |
JPS59215321A (en) | 1983-05-23 | 1984-12-05 | Sumitomo Chem Co Ltd | Reactive polymer having bound bifunctional ligand |
US4707352A (en) | 1984-01-30 | 1987-11-17 | Enzo Biochem, Inc. | Method of radioactively labeling diagnostic and therapeutic agents containing a chelating group |
US4652440A (en) | 1984-05-03 | 1987-03-24 | Paik Chang H | Method of stably radiolabeling antibodies with technetium and rhenium |
IL71947A (en) | 1984-05-29 | 1987-10-30 | Yeda Research And Dev Comp Ltd | Enzyme hydrazides and method for detection and determination of glycoconjugates |
US4659839A (en) | 1984-10-10 | 1987-04-21 | Mallinckrodt, Inc. | Coupling agents for radiolabeled antibody fragments |
US4918164A (en) | 1987-09-10 | 1990-04-17 | Oncogen | Tumor immunotherapy using anti-idiotypic antibodies |
US4678667A (en) | 1985-07-02 | 1987-07-07 | 501 Regents of the University of California | Macrocyclic bifunctional chelating agents |
GB8610551D0 (en) | 1986-04-30 | 1986-06-04 | Hoffmann La Roche | Polypeptide & protein derivatives |
IN165717B (en) | 1986-08-07 | 1989-12-23 | Battelle Memorial Institute | |
JPH0611290B2 (en) | 1986-11-05 | 1994-02-16 | 住友ベークライト株式会社 | Γ-ray sterilization method for polyvinyl alcohol gel |
US4861581A (en) | 1986-12-05 | 1989-08-29 | Cancer Biologics, Inc. | Detection of necrotic malignant tissue and associated therapy |
US5084266A (en) | 1988-02-03 | 1992-01-28 | The University Of Melbourne | Method for tumor imaging utilizing a labelled tumor specific antibody and a non-tumor reactive antibody |
US4857599A (en) | 1988-02-08 | 1989-08-15 | The Dow Chemical Company | Modified dense star polymers |
GB8820377D0 (en) | 1988-08-26 | 1988-09-28 | Offord R E | Chemical compounds |
GB9004538D0 (en) * | 1990-02-28 | 1990-04-25 | Offord Robin E | Chemical compounds |
US5011676A (en) | 1990-03-27 | 1991-04-30 | Thomas Jefferson University | Method to directly radiolabel antibodies for diagnostic imaging and therapy |
DE69126124T2 (en) * | 1990-09-28 | 1997-08-28 | Neorx Corp | POLYMERS CARRIER FOR RELEASING COVALENT-RELATED ACTIVE SUBSTANCES |
GB9102450D0 (en) | 1991-02-05 | 1991-03-20 | Sandoz Ltd | Improvements in or relating to organic compounds |
US5272253A (en) * | 1991-07-01 | 1993-12-21 | Eli Lilly And Company | Cluster conjugates of drugs with antibodies |
US6001364A (en) * | 1993-05-05 | 1999-12-14 | Gryphon Sciences | Hetero-polyoxime compounds and their preparation by parallel assembly |
US6174530B1 (en) * | 1993-05-05 | 2001-01-16 | Gryphon Sciences | Homogeneous polyoxime compositions and their preparation by parallel assembly |
WO1994025071A1 (en) | 1993-05-05 | 1994-11-10 | Keith Rose | Polyoxime compounds and their preparation |
-
1994
- 1994-05-05 EP EP94913192A patent/EP0697891B1/en not_active Expired - Lifetime
- 1994-05-05 AT AT94913192T patent/ATE191148T1/en not_active IP Right Cessation
- 1994-05-05 PT PT94913192T patent/PT697891E/en unknown
- 1994-05-05 JP JP52408094A patent/JP3734828B2/en not_active Expired - Fee Related
- 1994-05-05 DE DE69423753T patent/DE69423753T2/en not_active Expired - Fee Related
- 1994-05-05 AU AU65438/94A patent/AU686153B2/en not_active Ceased
- 1994-05-05 DK DK94913192T patent/DK0697891T3/en active
- 1994-05-05 CA CA002162157A patent/CA2162157A1/en not_active Abandoned
- 1994-05-05 ES ES94913192T patent/ES2146649T3/en not_active Expired - Lifetime
-
2000
- 2000-06-15 GR GR20000401389T patent/GR3033699T3/en not_active IP Right Cessation
- 2000-08-04 US US09/633,269 patent/US6663869B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US6663869B1 (en) | 2003-12-16 |
ATE191148T1 (en) | 2000-04-15 |
PT697891E (en) | 2000-09-29 |
AU6543894A (en) | 1994-11-21 |
GR3033699T3 (en) | 2000-10-31 |
JP3734828B2 (en) | 2006-01-11 |
CA2162157A1 (en) | 1994-11-10 |
DE69423753D1 (en) | 2000-05-04 |
EP0697891A1 (en) | 1996-02-28 |
DE69423753T2 (en) | 2000-11-02 |
DK0697891T3 (en) | 2000-09-04 |
EP0697891B1 (en) | 2000-03-29 |
AU686153B2 (en) | 1998-02-05 |
JPH08510210A (en) | 1996-10-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2146649T3 (en) | POLYOXIME COMPOUNDS AND THEIR PREPARATION. | |
ES2141610T3 (en) | COMPOUNDS WITH SPIRANIC ATOMS AND THEIR USE AS ELECTROLUMINISCENT MATERIALS. | |
CA2314226A1 (en) | Polymeric products containing modified carbon products and methods of making and using the same | |
DE69516006D1 (en) | AMMONIUM IONENE POLYMERS WITH BIOLOGICALLY ACTIVE ANIONS | |
EP0014843A3 (en) | Process and compounds for modifying macromolecular surfaces | |
CA2241787A1 (en) | Substituted aza- and diazacycloheptane and cyclooctane compounds and their use | |
DK392084D0 (en) | HARDWARE MATERIALS | |
FR2413434A1 (en) | THERMOPLASTIC MOLDING COMPOSITION BASED ON POLYESTERS | |
CA2273078A1 (en) | Use of nucleic acids bound to carrier macromolecules | |
DE69530052D1 (en) | Functional coating composition containing carbamate and acrylamide components | |
CA2133885A1 (en) | Crystalline inclusion complex of diclofenac with beta-cyclodextrin | |
EP0380139A3 (en) | Organic nonlinear optical material | |
EP0245893A3 (en) | Catalyst compositions | |
CA2032669A1 (en) | Process for incorporating o-hydroxyphenyl-s-triazines in organic polymers | |
BR9507963A (en) | Process for producing improved biological pesticides | |
WO1993015203A3 (en) | Polypeptides with fibronectin binding sites as modulators for matrix assembly | |
BR9810210A (en) | Improvements in or related to polymeric compositions | |
EP0149486A3 (en) | Detergent composition and gasoline composition containing same | |
BR9910099A (en) | Method to improve the appearance in composite coatings of extra bright color, and compositions for use in the same | |
JPS5650929A (en) | Polysulfone having carbon-carbon double bond on its side chain and its manufacture | |
ES2103194B1 (en) | ALUMINUM-PHTHALOCIANINE REACTIVE DYES. | |
ES458753A1 (en) | Coating agent for the production of coatings which are resistant to weathering | |
KR910004748A (en) | Curable Composition | |
JPS6420226A (en) | Production of modified epoxy resin | |
DE69417533D1 (en) | Improved bitumen compositions, their manufacturing processes and their applications |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 697891 Country of ref document: ES |